nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Andy Southan talks about ion channel research services at BioFocus
|
Carney, Steve |
|
2005 |
10 |
23-24 |
p. 1585-1587 3 p. |
artikel |
2 |
Antimalarial therapies
|
Trafford, Hugh |
|
2005 |
10 |
23-24 |
p. 1588-1590 3 p. |
artikel |
3 |
Changes to Drug Discovery Today for 2006
|
Carney, Steve |
|
2005 |
10 |
23-24 |
p. 1575-1576 2 p. |
artikel |
4 |
Druggability: selecting optimized drug candidates
|
Sugiyama, Yuichi |
|
2005 |
10 |
23-24 |
p. 1577-1579 3 p. |
artikel |
5 |
Erratum
|
|
|
2005 |
10 |
23-24 |
p. 1695- 1 p. |
artikel |
6 |
Essential properties of drug-targeting delivery systems
|
Petrak, Karel |
|
2005 |
10 |
23-24 |
p. 1667-1673 7 p. |
artikel |
7 |
Finding new drug targets in the 21st century
|
Lindsay, Mark A. |
|
2005 |
10 |
23-24 |
p. 1683-1687 5 p. |
artikel |
8 |
From ligand design to therapeutic efficacy: the challenge for nicotinic receptor research
|
Cassels, Bruce K. |
|
2005 |
10 |
23-24 |
p. 1657-1665 9 p. |
artikel |
9 |
Hope for Huntington's from an old antibiotic
|
Ashraf, Haroon |
|
2005 |
10 |
23-24 |
p. 1582-1583 2 p. |
artikel |
10 |
Interdisciplinary research and education at the biology-engineering-computer science interface: a perspective (reprinted article)
|
Tadmor, Brigitta |
|
2005 |
10 |
23-24 |
p. 1706-1712 7 p. |
artikel |
11 |
Keynote review: Histamine H3 receptor antagonists reach out for the clinic
|
Celanire, Sylvain |
|
2005 |
10 |
23-24 |
p. 1613-1627 15 p. |
artikel |
12 |
Massive variability in a stable binding protein
|
Sutherland, Stephani |
|
2005 |
10 |
23-24 |
p. 1580- 1 p. |
artikel |
13 |
Medicinal mushroom cuts off prostate cancer cells' blood supply
|
Johnston, Nicole |
|
2005 |
10 |
23-24 |
p. 1584- 1 p. |
artikel |
14 |
Microarrays, databases and hard, hard sums
|
Bousfield, David |
|
2005 |
10 |
23-24 |
p. 1594-1597 4 p. |
artikel |
15 |
Monitor – An inhibitor of insulin-like growth factor-1 receptor kinase with in vivo antitumour activity
|
Westwell, Andrew D. |
|
2005 |
10 |
23-24 |
p. 1703-1704 2 p. |
artikel |
16 |
Monitor – chemistry
|
Westwell, Andrew D. |
|
2005 |
10 |
23-24 |
p. 1703- 1 p. |
artikel |
17 |
Monitor – New TRPV1-targeting agents for pain management
|
González-Muñiz, Rosario |
|
2005 |
10 |
23-24 |
p. 1704-1705 2 p. |
artikel |
18 |
More songs o' science
|
Rowe, Raymond C. |
|
2005 |
10 |
23-24 |
p. 1611-1612 2 p. |
artikel |
19 |
Multiple sclerosis poses tough drug development challenges
|
Senior, Kathryn |
|
2005 |
10 |
23-24 |
p. 1583-1584 2 p. |
artikel |
20 |
Nanomedicine transforms drug delivery
|
Shaffer, Catherine |
|
2005 |
10 |
23-24 |
p. 1581-1582 2 p. |
artikel |
21 |
Novel and emerging therapies for asthma
|
Leath, Thomas M. |
|
2005 |
10 |
23-24 |
p. 1647-1655 9 p. |
artikel |
22 |
Practical proteomic biomarker discovery: taking a step back to leap forward
|
Listgarten, Jennifer |
|
2005 |
10 |
23-24 |
p. 1697-1702 6 p. |
artikel |
23 |
Predicting protein druggability
|
Hajduk, Philip J. |
|
2005 |
10 |
23-24 |
p. 1675-1682 8 p. |
artikel |
24 |
Rapid growth in Israel's life science industry
|
Barki, Therese |
|
2005 |
10 |
23-24 |
p. 1591-1593 3 p. |
artikel |
25 |
Representativity of target families in the Protein Data Bank: impact for family-directed structure-based drug discovery
|
Mestres, Jordi |
|
2005 |
10 |
23-24 |
p. 1629-1637 9 p. |
artikel |
26 |
Significance of release technology in tissue engineering
|
Tabata, Yasuhiko |
|
2005 |
10 |
23-24 |
p. 1639-1646 8 p. |
artikel |
27 |
Sourcing natural killer cells for antitumor immunotherapy
|
Bradbury, Jane |
|
2005 |
10 |
23-24 |
p. 1581- 1 p. |
artikel |
28 |
Storage and transmission of microarray images
|
Luo, Yu |
|
2005 |
10 |
23-24 |
p. 1689-1695 7 p. |
artikel |
29 |
The druggable genome: an update
|
Russ, Andreas P. |
|
2005 |
10 |
23-24 |
p. 1607-1610 4 p. |
artikel |
30 |
Therapies for rheumatoid arthritis: hope springs eternal
|
Smith, Robert J. |
|
2005 |
10 |
23-24 |
p. 1598-1606 9 p. |
artikel |